Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
6d
PTC Therapeutics, Inc.: PTC Therapeutics Announces FDA Target Regulatory Action Date for Sepiapterin and Lancet Publication of Phase 3 Trial Results
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the FDA has set a target regulatory action date of July 29, 2025, for the review of the New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
The Vessel to reopen
Sued by Murdoch’s firms
Gold hits fresh high
Helicopter hits radio tower
Ex-Iron Maiden singer dies
Oscar makes landfall
New Mexico flash flooding
Faces new lawsuits
American activist Wair dies
Minks released, 2 arrested
Had multiple drugs in body?
Hezbollah assets targeted
SCOTUS rejects Cohen suit
To roll out AI agents in Nov
Out with ruptured Achilles
Bitcoin nears $70,000
Advance to World Series
Anti-missile system in Israel
GA county to sue BioLab
SCOTUS rejects bid
NYC subway death trial
Judge weighs Louisiana law
$1 million daily giveaway
Arizona official pleads guilty
Files suit over fake drugs
NC tops 1 million votes
To get up to $325M grant
University protest arrests
Tours Helene storm damage
Stroke prevention guidance
AR marijuana votes blocked
Bacteria cases rise in FL
Urges support for Ukraine
Washington state shooting
Feedback